Human corticotropin-releasing hormone and thyrotropin-releasing hormone modulate the hypercapnic ventilatory response in humans

European Journal of Clinical Investigation

Volumn 26, Issue 11, 1996, Pages 989-995

  Schulz, R ^a,d   Nink, M ^b   Werner, G S ^a   Andreas, S ^a   Kreuzer, H ^a   Beyer, J ^b   Lehnert, H ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Corticotropin releasing hormone; Hormone; Humans; Hypercapnic ventilatory response; Thyrotropin releasing

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; PLACEBO; PROTIRELIN;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; CHEMORECEPTOR; CHEMOSENSITIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DYSPNEA; FLUSHING; HEART PALPITATION; HUMAN; HUMAN EXPERIMENT; HYPERCAPNIA; INTRAVENOUS DRUG ADMINISTRATION; LUNG VENTILATION; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

EID: 0029902938     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.2130573.x     Document Type: Article

References (45)

1. Griffiths EC. Thyrotropin releasing hormone: endocrine and central effects. Psychoneuroendocrinology 1985;10:225-35.
2. Horita A, Carino MA, Lai H. Pharmacology of thyrotropin releasing hormone. Annu Rev Pharmacol Toxicol 1986;26:311-32.
3. Jackson IMD. Thyrotropin releasing hormone. New Engl J Med 1982;306:145-55.
4. Krahn DD, Gornell BA, Levine AS. Morley JE. Behavioral effects of corticotropin releasing factor: localization and characterization of central effects. Brain Res 1988;443:63-9.
5. Lehnert H, Beyer J, Nink M, Schrezenmeir J, Krause U. Die Bedeutung von Corticotropin-releasing-factor für die Regulation autonomer und endokriner Funktionen. Med Klin 1988; 83:763-8.
6. Lehnert H, Nink M, Mann K, Röschke J, Hellhammer DH. Extrapituitary effects of corticotropin-releasing hormone and thyrotropin-releasing hormone. Neuropsychobiology 1993;28: 54-61.
7. Taylor AL, Fishman LM. Corticotropin-releasing hormone. N. Engl J Med 1988;319:213-22.
8. Nink M, Huber I, Krause U, Schulz V, Beyer J, Lehnert H. Thyrotropin releasing hormone (TRH) und humaner Corticotropin releasing factor (hCRH) als Modulatoren der Atmung beim Menschen: Physiologie und Klinik. Prax Klin Pneumol 1988;42:25-30.
9. Nink M, Krause U, Lehnert H et al. Thyrotropin-releasing hormone has stimulatory effects on ventilation in humans. Acta Physiol Scand 1991;141:309-18.
10. Nink M, Huber I, Oppermann D, Krause U, Schulz V. Corticotropin releasing factor - a respiratory simulant. Eur J Respir Dis 1986;69(Suppl. 146):118.
11. Nink M, Krause U, Lehnert H, Schulz V, Shulz R, Beyer J. Untersuchungen zur Einflußnahme der Releasing Hormone TRH und CRH auf die Atemregulation. Pneumologie 1991;45: 246-8.
12. Huber I, Krause U, Nink M, Lehnert H, Beyer J. Dexamethasone does not suppress the respiratory analeptic effect of corticotropin releasing hormone. J Clin Endocrinol Metab 1989;69: 440-2.
13. Lambertsen GJ. Effects of drugs and hormones on the respiratory response to carbon dioxide. In: Senn WO, Rahn H, eds. Handbook of Physiology, Section 3: Respiration, Vol. 1. Washington D.C.: American Physiological Society, 1964:545-55.
14. Read DJC. A clinical method for assessing the ventilatory response to carbon dioxide. Austral Ann Med 1967;16:20-32.
15. Lloyd BB, Jukes MGM, Cunningham DJC. The relation between alveolar oxygen pressure and the respiratory response to carbon dioxide. Q. J Exp Physiol 1958;43:214-27.
16. Iversen E. Intra- and extravascular turnover of thyrotropin releasing hormone in normal man. J Endocrinol 1988;118: 511-16.
17. Moss IR, Denavit-Saubie M, Eldridge FL, Gillis RA, Herkenham M, Lahiri S. Neuromodulators and transmitters in respiratory control. Fed Proc 1986;45:2133-47.
18. Hermus ARMM, Pieters FFM. Willemsen et al. Hypotensive effects of ovine and human corticotropin-releasing factors in man. Eur J Clin Pharmacol 1987;31:531-4.
19. Schürmeyer TH, Avgerinos PC, Gold PW et al. Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. J Clin Endocrinol Metab 1984;59:1103-8.
20. Zheng D, Chen HS, Hu DY. Cardiovascular mechanisms of thyrotropin-releasing hormone against experimental hemorrhagic shock. Circ Shock 1992;36:169-73.
21. Grunt M, Glaser J, Schmidhuber H, Pauschinger P. Born J. Effects of corticotropin-releasing factor on isolated rat heart activity. Am J Physiol 1993;264:H1124-H1129.
22. Conaglen JV, Donald RA, Espiner EA, Livesey JH, Nicholls MG. The effect of ovine corticotropin-releasing factor on catecholamine, vasopressin, and aldosterone secretion in normal man. J Clin Endocrinol Metab 1984;58:463-6.
23. Bennet L, Gluckman PD, Johnston BM. The central effects of thyrotropin-releasing hormone on the breathing movements and electrocortical activity of the fetal sheep. Pediatr Res 1988;23: 72-5.
24. Bennet L, Johnston BM, Vale WW, Gluckman PD. The effects of corticotropin-releasing factor and two antagonists on breathing movements in fetal sheep. J Physiol 1990;421:1-11.
25. Böhmer G, Schmid K, Ramsbott M. Effects of corticotropin releasing factor on the central respiratory activity. Eur J Pharmacol 1990;182:405-11.
26. Koivusalo F, Paakari I, Leppäluoto J, Karrpanen H. The effect of centrally administered TRH on blood pressure, heart rate and ventilation in rat. Acta Physiol Scand 1979;106:83-6.
27. Joseph SDA, Pilcher WH, Knigge KM. Anatomy of the corticotropin releasing factor and opiomelanocortin systems of the brain. Fed Proc 1985;44:100-7.
28. De Souza EB, Kuhar MJ. Corticotropin releasing factor receptors in the pituitary gland and the central nervous system: methods and overview. Methods Enzymol 1986;124:560-90.
29. Valentino R, Foote SL, Aston-Jones G. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 1983;270:363-7.
30. Palkovits M, Mezey E, Eskay RL, Brownstein MJ. Innervation of the nucleus of the solitary tract and the dorsal vagal nucleus by thyrotropin-releasing hormone containing raphe neurons. Brain Res 1986;373:246-51.
31. Pazos A, Cortes R, Palacios JM. Thyrotropin releasing hormone receptor binding sites: autoradiographic distribution in the rat and guinea pig brain. J Neurochem. 1985;45:1448-63.
32. Carter DA, Lightman SL. Cardiorespiratory actions of substance P, TRH and 5-HT in the nucleus tractus solitariusof rats: evidence for functional interactions of neuropeptides and amine neurotransmitters. Neuropeptides 1985;6:425-36.
33. Dekin MS, Richerson GB, Getting PA. Thyrotropin releasing hormone induces rhythmic bursting in neurons of the nucleus tractus solitarius. Science 1985;229:67-9.
34. McGown TJ, Hedner JA, Towle AC, Breese GR, Mueller RA. Brainstem localisation of a thyrotropin releasing hormone-induced change in respiratory function. Brain Res. 1986;373: 189-96.
35. Hedner J, McGown TJ, Mueller RA, Hedner T, Jonason J, Breese GR. Respiratory stimulant effect by TRH into the mesencephalic region in the rat. Acta Physiol Scand 1987;130: 69-75.
36. Mueller RA, Towle AC, Breese GR. The role of vagal afferents and carbon dioxide in the respiratory response to thyrotropin-releasing hormone. Regul Peptides 1985;10:157-66.
37. Banks WA, Kastin AJ. Permeability of the blood brain barrier to neuropeptides: the case for penetration. Psychoneuroendocrinology 1985;10:385-99.
38. Suhonen-Malm S. Thyrotropin-releasing hormone immunoreactivity in human blood, urine, spinal fluid, amniotic fluid, saliva and gastric juice. Acta Endocrinol 1987;114:552-8.
39. Suda T, Tozawa F, Mouri T, Demura H, Shizume K. Presence of immunoreactive corticotropin-releasing factor in human cerebrospinal fluid. J Clin Endocrinol Metab 1983;57:225-6.
40. Brooks BR, Kalin N, Beaulieu DA, Barksdale C, Sufit RL, Dills DG. Thyrotropin releasing hormone uptake into serum and cerebrospinal fluid following intravenous or subcutaneous administration. Neurol Res 1988;10:236-8.
41. Black PM. Neuropeptides in cerebrospinal fluid. Neurosurgery 1982;11:550-5.
42. Nink M, Beyer J, Krause U, Holzhauer F, Junginger Th, Lehnert H. Effects of corticotropin-releasing hormone on the postoperative course of elderly patients under long-term artificial respiration. Acta Endocrinol 1992:127:200-4.
43. Lehnert H, Mann K, Röschke J, Nink M, Aldenhoff J, Benkert O, Beyer J. Therapeutic value of corticotropin-releasing hormone in patients suffering from sleep apnea syndrome (abstract). Exp Clin Endocrinol 1993;101(Suppl. 1):42.
44. Nink M, Krause U, Lehnert H, Beyer J. Safety and side effects of human and ovine corticotropin-releasing hormone administration in man. Klin Wochenschr 1991;69:185-95.
45. Nink M, Salomon E, Coutinho M. et al. Corticotropin-releasing hormone (CRH) is a respiratory stimulant in humans: a comparative study of human and ovine CRH. Life Sci 1994;54:1793-9.